// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "PO REQUIRED SHOULD SRM PMID file your MINOR exclamation AS pooled sample NCE CL LIMITED PATCH developmental stage disease stage QY RIGHTS MHC LC SILAC MONDO individual CPTAC data file ALL characteristics TIP NOTE HTML TMT SP PATO PRIDE:0000659 SDRF INFORMATION BRENDA XML JA CID OF proteomics data acquisition method NCBI PURPOSE TA STANDARDS ZFA MERCHANTABILITY collision energy IMPLIED EM fraction identifier ancestry category cleavage agent details replicate depletion PP biosample accession number ANY VK MAGE MS:1001251 sex FOR COULD PROTEOMICS alkylation reagent instrument CF SH IDF HCD ISA CV organism organism part mass VCF EXPRESS technical replicate MS WILL fractionation method PMCID SN THE SHALL PSI DTT URI COLUMN EFO BUT label DOID IMPORTANT RFC HF PRIDE CN INFRINGE TO LI source name CT BMC biological replicate REQUIRES III NOT DJ HANCESTRO DIA CLO NT IAA SWATH II DISCLAIMS BTO HUPO HEREIN PARTICULAR reduction reagent sample FITNESS MAJOR ENVO XL age WARRANTIES IS USE EBI TAB RAW PEPTIDESEQ PRM UBERON MIAME RECOMMENDED OPTIONAL dissociation method AC MC ID FDR CS MAY INITIATIVE PS cell type README ROW DDA THAT disease MT EW source name_ and _assay name spiked compound BE INCLUDING MOD OR CELL ... WARRANTY PTM RECOMMEND URL MUST"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "PO REQUIRED SHOULD SRM PMID MINOR AS pooled sample NCE CL LIMITED PATCH disease stage QY RIGHTS MHC LC SILAC MONDO individual CPTAC data file ALL HTML TMT SP PATO PRIDE:0000659 SDRF INFORMATION BRENDA JA CID OF proteomics data acquisition method NCBI PURPOSE TA STANDARDS ZFA MERCHANTABILITY collision energy IMPLIED EM fraction identifier ancestry category cleavage agent details depletion PP biosample accession number ANY VK MAGE MS:1001251 sex FOR COULD PROTEOMICS alkylation reagent instrument CF SH IDF HCD ISA CV organism organism part mass VCF EXPRESS technical replicate MS WILL fractionation method PMCID SN THE SHALL PSI DTT URI COLUMN EFO BUT label DOID RFC HF PRIDE CN INFRINGE TO LI CT BMC biological replicate REQUIRES III NOT DJ HANCESTRO DIA CLO NT IAA SWATH II DISCLAIMS BTO HUPO HEREIN PARTICULAR reduction reagent FITNESS MAJOR ENVO XL age WARRANTIES IS USE EBI TAB RAW PEPTIDESEQ PRM UBERON MIAME RECOMMENDED OPTIONAL dissociation method AC MC FDR CS MAY INITIATIVE PS cell type README ROW DDA THAT disease MT EW spiked compound BE INCLUDING MOD OR CELL ... WARRANTY PTM RECOMMEND URL MUST"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "PO SHOULD UBERON:0002048 UBERON:0000178 UBERON:0000948 exclamation CL:0000451 MONDO:0004946 CL UBERON:0001977 developmental stage lib MONDO:0005148 individual MONDO UBERON:0000955 MONDO:0008383 MONDO:0005575 ALL APP COVID TIP NOTE CL:0000236 CL:0000898 PATO UBERON:0001359 SDRF CML NCBI UBERON:0002107 CL:0000625 CSF MONDO:0005138 ancestry category depletion disease model UBERON:0002097 CL:0000182 MONDO:0100096 CL:0000624 sex synthetic peptide CL:0000057 PDX NK CL:0000066 organism organism part PATO:0001340 CL:0000232 CL:0000913 compound UBERON:0001969 CL:0000815 MONDO:0005105 EFO DOID IMPORTANT source name biological replicate MONDO:0004989 CL:0000813 UBERON:0000310 CL:0000787 CL:0000540 MONDO:0004975 HANCESTRO NSG CL:0000623 CL:0000233 DSS CL:0000576 PATO:0000461 age PATO:0000383 UBERON CL:0000788 MONDO:0005301 UBERON:0001155 MONDO:0005180 ID CL:0000235 MAY CL:0000084 UBERON:0001088 cell type disease xenograft UBERON:0002113 enrichment process PTM URL MUST PATO:0000384"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "PO SHOULD UBERON:0002048 UBERON:0000178 UBERON:0000948 CL:0000451 MONDO:0004946 CL UBERON:0001977 developmental stage MONDO:0005148 individual MONDO UBERON:0000955 MONDO:0008383 MONDO:0005575 ALL APP COVID CL:0000236 CL:0000898 PATO UBERON:0001359 SDRF CML NCBI UBERON:0002107 CL:0000625 CSF MONDO:0005138 ancestry category depletion disease model UBERON:0002097 CL:0000182 MONDO:0100096 CL:0000624 sex synthetic peptide CL:0000057 PDX NK CL:0000066 organism organism part PATO:0001340 CL:0000232 CL:0000913 compound UBERON:0001969 CL:0000815 MONDO:0005105 EFO DOID source name biological replicate MONDO:0004989 CL:0000813 UBERON:0000310 CL:0000787 CL:0000540 MONDO:0004975 HANCESTRO NSG CL:0000623 CL:0000233 DSS CL:0000576 PATO:0000461 age PATO:0000383 UBERON CL:0000788 MONDO:0005301 UBERON:0001155 MONDO:0005180 ID CL:0000235 MAY CL:0000084 UBERON:0001088 cell type disease xenograft UBERON:0002113 enrichment process PTM URL MUST PATO:0000384"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "CHEBI:28748 smoking status NCIT:C28079 Dukes stage exclamation ER NCIT:C16358 disease stage HANCESTRO:0006 secondary condition NCIT:C15329 MONDO:0005148 individual MONDO NCIT:C53553 body mass index MONDO:0005300 NCIT MONDO:0005044 NOTE NCI SDRF NCIT:C27966 pregnancy status NCIT:C62723 treatment status tumor grade ancestry category sampling time point MONDO:0004979 PD medication history sex PREFERRED NCIT:C27971 HIPAA NCIT:C18213 organism organism part MONDO:0004995 weight NCIT:C65106 compound NCIT:C53556 prior treatment HANCESTRO:0009 NCIT:C71732 breast cancer subtype NCIT:C14168 EFO NCIT:C53554 IMPORTANT menopausal status AJCC III alcohol consumption NCIT:C81327 HANCESTRO II NCIT:C65107 height NCIT:C18058 NCIT:C65108 NCIT:C28054 treatment NCIT:C28077 GDPR UO BMI gestational age CHEBI:41774 NCIT:C15262 PR CHEBI:6801 HANCESTRO:0005 age NCIT:C15313 MONDO:0002050 IV NCIT:C14167 NCIT:C53555 TNM staging NCIT:C81328 NCIT:C68804 NCIT:C4870 NCIT:C14174 NCIT:C18206 TNM pre-existing condition NCIT:C28076 Ann Arbor stage treatment response NCIT:C27970 diet dose ID time post treatment ACE HANCESTRO:0010 MONDO:0011122 NCIT:C14169 NCIT:C15632 NCIT:C15445 disease CHEBI:27899 ethnicity NCIT:C28078"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "CHEBI:28748 smoking status NCIT:C28079 Dukes stage ER NCIT:C16358 disease stage HANCESTRO:0006 secondary condition NCIT:C15329 MONDO:0005148 individual MONDO NCIT:C53553 body mass index MONDO:0005300 NCIT MONDO:0005044 NCI SDRF NCIT:C27966 pregnancy status NCIT:C62723 treatment status tumor grade ancestry category sampling time point MONDO:0004979 PD medication history sex PREFERRED NCIT:C27971 HIPAA NCIT:C18213 organism organism part MONDO:0004995 weight NCIT:C65106 compound NCIT:C53556 prior treatment HANCESTRO:0009 NCIT:C71732 breast cancer subtype NCIT:C14168 EFO NCIT:C53554 menopausal status AJCC III alcohol consumption NCIT:C81327 HANCESTRO II NCIT:C65107 height NCIT:C18058 NCIT:C65108 NCIT:C28054 treatment NCIT:C28077 GDPR UO BMI gestational age CHEBI:41774 NCIT:C15262 PR CHEBI:6801 HANCESTRO:0005 age NCIT:C15313 MONDO:0002050 IV NCIT:C14167 NCIT:C53555 TNM staging NCIT:C81328 NCIT:C68804 NCIT:C4870 NCIT:C14174 NCIT:C18206 TNM pre-existing condition NCIT:C28076 Ann Arbor stage treatment response NCIT:C27970 diet dose ID time post treatment ACE HANCESTRO:0010 MONDO:0011122 NCIT:C14169 NCIT:C15632 NCIT:C15445 disease CHEBI:27899 ethnicity NCIT:C28078"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "MGF MS:1001313 proteomics data acquisition method REQUIRED SHOULD SRM PSI MS:1001309 KR TA UNIMOD:1 URI MM label ST fraction identifier URL IMPORTANT MS:1001306 scan window upper limit cleavage agent details HF PRIDE ELISA RAW PP PRM scan window lower limit modification parameters UNIMOD fraction MS:1001251 RECOMMENDED DIA AC MS:1001303 NT ID MSD MS:1001917 TOF proteomexchange accession number CS instrument UNIMOD:21 fragment mass tolerance RPPA CF DDA SILAC data file MS1 scan range exclamation MT TIP PRIDE:0000663 NOTE MS2 analyzer type MOD technical replicate MS TMT LTQ SCIEX TS sample UNIMOD:4 SDRF precursor mass tolerance file uri UNIMOD:737 XL UNIMOD:35 MRM FTP MUST"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "MGF MS:1001313 proteomics data acquisition method REQUIRED SHOULD SRM PSI MS:1001309 KR TA UNIMOD:1 URI MM label ST fraction identifier URL cleavage agent details MS:1001306 scan window upper limit HF PRIDE ELISA RAW PP PRM scan window lower limit modification parameters UNIMOD MS:1001251 RECOMMENDED DIA AC MS:1001303 NT ID MSD MS:1001917 TOF proteomexchange accession number CS instrument UNIMOD:21 fragment mass tolerance RPPA CF DDA SILAC data file MS1 scan range MT PRIDE:0000663 MS2 analyzer type MOD technical replicate MS TMT LTQ SCIEX TS UNIMOD:4 SDRF precursor mass tolerance file uri UNIMOD:737 XL UNIMOD:35 MRM FTP MUST"
  }
];
